Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis


Lilly highlights retatrutide, Taltz and Zepbound data across rheumatologic diseases and obesity


Lilly and Hims & Hers expand access to Zepbound and Foundayo


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

A Versatile Solution for Host Cell Proteins (HCPs) and Aggregates Removal for mAbs Purification

Presented by Catherine Allioux & Gareth Leach, Ph.D
08th June 2017


Advances in Mass Spectrometry for the Analysis and Bioanalysis of Antibody Drug Conjugates

Presented by Arnaud Delobel, PhD, R&D Director at Quality Assistance sa
12th September 2017


Qualification of Raw Materials and Cell Substrates for Biomanufacturing

Presented by Maura C. Kibbey, Ph.D., Director, Science & Standards, Global Biologics, U.S. Pharmacopeia and Martin Wisher, PhD, Global Head of Regulatory Affairs at Merck
16th January 2020


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia